Teachers Advisors’s Northwest Biotherapeutics, Inc. Common stock NWBO Stock Holding History

Teachers Advisors’s Portfolio NWBO Stock Details NWBO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q2	–	Sell	-71,806	Closed	-$105K	–	3264
2016 Q1	$105K	Hold	71,806	–	–	﹤0.01%	2935
2015 Q4	$230K	Buy	71,806 +4,059	+6%	+$19.5K	﹤0.01%	2820
2015 Q3	$423K	Hold	67,747	–	–	﹤0.01%	2490
2015 Q2	$673K	Buy	67,747 +9,630	+17%	+$84.3K	﹤0.01%	2340
2015 Q1	$428K	Buy	58,117 +7,850	+16%	+$52.8K	﹤0.01%	2526
2014 Q4	$269K	Hold	50,267	–	–	﹤0.01%	2773
2014 Q3	$253K	Hold	50,267	–	–	﹤0.01%	2766
2014 Q2	$337K	Buy	+50,267	New	+$320K	﹤0.01%	2674

Other funds holding NWBO

WIM

Woodford Investment Management London, United Kingdom $310M AUM 17.41% 1-Year Est. Return

Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Teachers Advisors's NWBO Position: Q2 2016 in Review

Teachers Advisors sold out of Northwest Biotherapeutics, Inc. Common stock (NWBO) in Q2 2016, closing a stake of 71,806 shares — an estimated $105K sold.

Teachers Advisors first reported a position in NWBO in Q2 2014 and held it in 8 quarters. The position peaked at $673K in Q2 2015. 64 funds tracked by Wall St. Rank hold NWBO as of Q2 2016.

Teachers Advisors reported no remaining Northwest Biotherapeutics, Inc. Common stock position as of Q2 2016 after selling out during the quarter.
Teachers Advisors sold 71,806 Northwest Biotherapeutics, Inc. Common stock shares in Q2 2016, an estimated $105K.
Teachers Advisors first reported a position in Northwest Biotherapeutics, Inc. Common stock in Q2 2014 and held it in 8 quarters.
Teachers Advisors's Northwest Biotherapeutics, Inc. Common stock position peaked at $673K in Q2 2015.
64 funds tracked by Wall St. Rank held Northwest Biotherapeutics, Inc. Common stock as of Q2 2016.

Based on Teachers Advisors's 13F filing for Q2 2016, filed 11 Aug 2016.